These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 12681450)
1. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells. Fung MM; Rohwer F; McGuire KL Cell Signal; 2003 Jun; 15(6):625-36. PubMed ID: 12681450 [TBL] [Abstract][Full Text] [Related]
2. Interleukin-6-induced STAT3 transactivation and Ser727 phosphorylation involves Vav, Rac-1 and the kinase SEK-1/MKK-4 as signal transduction components. Schuringa JJ; Jonk LJ; Dokter WH; Vellenga E; Kruijer W Biochem J; 2000 Apr; 347 Pt 1(Pt 1):89-96. PubMed ID: 10727406 [TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways. Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952 [TBL] [Abstract][Full Text] [Related]
4. The involvement of PI 3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Kuo ML; Chuang SE; Lin MT; Yang SY Oncogene; 2001 Feb; 20(6):677-85. PubMed ID: 11314001 [TBL] [Abstract][Full Text] [Related]
5. The phosphotidyl inositol 3-kinase/Akt signal pathway is involved in interleukin-6-mediated Mcl-1 upregulation and anti-apoptosis activity in basal cell carcinoma cells. Jee SH; Chiu HC; Tsai TF; Tsai WL; Liao YH; Chu CY; Kuo ML J Invest Dermatol; 2002 Nov; 119(5):1121-7. PubMed ID: 12445202 [TBL] [Abstract][Full Text] [Related]
6. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells. Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439 [TBL] [Abstract][Full Text] [Related]
7. Differential effects of kinase cascade inhibitors on neoplastic and cytokine-mediated cell proliferation. Shelton JG; Moye PW; Steelman LS; Blalock WL; Lee JT; Franklin RA; McMahon M; McCubrey JA Leukemia; 2003 Sep; 17(9):1765-82. PubMed ID: 12970777 [TBL] [Abstract][Full Text] [Related]
8. Mitogenic and antiapoptotic actions of hepatocyte growth factor through ERK, STAT3, and AKT in endothelial cells. Nakagami H; Morishita R; Yamamoto K; Taniyama Y; Aoki M; Matsumoto K; Nakamura T; Kaneda Y; Horiuchi M; Ogihara T Hypertension; 2001 Feb; 37(2 Pt 2):581-6. PubMed ID: 11230338 [TBL] [Abstract][Full Text] [Related]
10. The Ras/Raf/MEK/extracellular signal-regulated kinase pathway induces autocrine-paracrine growth inhibition via the leukemia inhibitory factor/JAK/STAT pathway. Park JI; Strock CJ; Ball DW; Nelkin BD Mol Cell Biol; 2003 Jan; 23(2):543-54. PubMed ID: 12509453 [TBL] [Abstract][Full Text] [Related]
11. Synergy between PI3K/Akt and Raf/MEK/ERK pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells. Shelton JG; Steelman LS; White ER; McCubrey JA Cell Cycle; 2004 Mar; 3(3):372-9. PubMed ID: 14726697 [TBL] [Abstract][Full Text] [Related]
12. 8p12 stem cell myeloproliferative disorder: the FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways. Guasch G; Ollendorff V; Borg JP; Birnbaum D; Pébusque MJ Mol Cell Biol; 2001 Dec; 21(23):8129-42. PubMed ID: 11689702 [TBL] [Abstract][Full Text] [Related]
13. Cytokines promote motoneuron survival through the Janus kinase-dependent activation of the phosphatidylinositol 3-kinase pathway. Dolcet X; Soler RM; Gould TW; Egea J; Oppenheim RW; Comella JX Mol Cell Neurosci; 2001 Dec; 18(6):619-31. PubMed ID: 11749038 [TBL] [Abstract][Full Text] [Related]
14. Downstream effectors of oncogenic ras in multiple myeloma cells. Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720 [TBL] [Abstract][Full Text] [Related]
15. Requirement for the PI3K/Akt pathway in MEK1-mediated growth and prevention of apoptosis: identification of an Achilles heel in leukemia. Blalock WL; Navolanic PM; Steelman LS; Shelton JG; Moye PW; Lee JT; Franklin RA; Mirza A; McMahon M; White MK; McCubrey JA Leukemia; 2003 Jun; 17(6):1058-67. PubMed ID: 12764369 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways. Kunioku H; Inoue K; Tomida M Neurosci Lett; 2001 Aug; 309(1):13-6. PubMed ID: 11489535 [TBL] [Abstract][Full Text] [Related]
17. ERK and PI3K negatively regulate STAT-transcriptional activities in human melanoma cells: implications towards sensitization to apoptosis. Krasilnikov M; Ivanov VN; Dong J; Ronai Z Oncogene; 2003 Jun; 22(26):4092-101. PubMed ID: 12821943 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. Chen RH; Chang MC; Su YH; Tsai YT; Kuo ML J Biol Chem; 1999 Aug; 274(33):23013-9. PubMed ID: 10438468 [TBL] [Abstract][Full Text] [Related]
19. Induction of apoptosis in IL-3-dependent hematopoietic cell lines by guanine nucleotide depletion. Gu JJ; Gathy K; Santiago L; Chen E; Huang M; Graves LM; Mitchell BS Blood; 2003 Jun; 101(12):4958-65. PubMed ID: 12609835 [TBL] [Abstract][Full Text] [Related]
20. Activation of PI3K is indispensable for interleukin 7-mediated viability, proliferation, glucose use, and growth of T cell acute lymphoblastic leukemia cells. Barata JT; Silva A; Brandao JG; Nadler LM; Cardoso AA; Boussiotis VA J Exp Med; 2004 Sep; 200(5):659-69. PubMed ID: 15353558 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]